Literature DB >> 17932329

Mounting evidence that fibrosis generates a major mechanism for atrial fibrillation.

Madison S Spach.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17932329     DOI： 10.1161/CIRCRESAHA.107.163956

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  23 in total

1.  Spatiotemporal induction of matrix metalloproteinase-9 transcription after discrete myocardial injury.

Authors:  Rupak Mukherjee; Gregory P Colbath; Charles D Justus; James A Bruce; Claire M Allen; Kenneth W Hewett; J Philip Saul; Robert G Gourdie; Francis G Spinale
Journal:  FASEB J       Date:  2010-06-08       Impact factor: 5.191

2.  Loading effect of fibroblast-myocyte coupling on resting potential, impulse propagation, and repolarization: insights from a microstructure model.

Authors:  Vincent Jacquemet; Craig S Henriquez
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-02-29       Impact factor: 4.733

3.  Long-term outcomes of radiofrequency catheter ablation for atrial fibrillation in rheumatic heart disease patients with mild mitral stenosis.

Authors:  Jindong Chen; Hao Wang; Liang Zhao
Journal:  J Interv Card Electrophysiol       Date:  2019-05-04       Impact factor: 1.900

Review 4.  The adverse cardiac effects of Di(2-ethylhexyl)phthalate and Bisphenol A.

Authors:  Nikki Gillum Posnack
Journal:  Cardiovasc Toxicol       Date:  2014-12       Impact factor: 3.231

5.  Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing.

Authors:  J Zhao; J Li; W Li; Y Li; H Shan; Y Gong; B Yang
Journal:  Br J Pharmacol       Date:  2010-01-15       Impact factor: 8.739

6.  Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-β1.

Authors:  Dolkun Rahmutula; Gregory M Marcus; Emily E Wilson; Chun-Hua Ding; Yuanyuan Xiao; Agnes C Paquet; Rebecca Barbeau; Andrea J Barczak; David J Erle; Jeffrey E Olgin
Journal:  Cardiovasc Res       Date:  2013-04-23       Impact factor: 10.787

7.  Association between transforming growth factor beta1 polymorphisms and atrial fibrillation in essential hypertensive subjects.

Authors:  Yongzheng Wang; Xuwei Hou; Yuliang Li
Journal:  J Biomed Sci       Date:  2010-03-31       Impact factor: 8.410

8.  Increased Susceptibility to Atrial Fibrillation Secondary to Atrial Fibrosis in Transgenic Goats Expressing Transforming Growth Factor-β1.

Authors:  Irina A Polejaeva; Ravi Ranjan; Christopher J Davies; Misha Regouski; Justin Hall; Aaron L Olsen; Qinggang Meng; Heloisa M Rutigliano; Derek J Dosdall; Nathan A Angel; Frank B Sachse; Thomas Seidel; Aaron J Thomas; Rusty Stott; Kip E Panter; Pamela M Lee; Arnaud J Van Wettere; John R Stevens; Zhongde Wang; Rob S MacLeod; Nassir F Marrouche; Kenneth L White
Journal:  J Cardiovasc Electrophysiol       Date:  2016-08-30

9.  Histopathological substrate for chronic atrial fibrillation in humans.

Authors:  Bich Lien Nguyen; Michael C Fishbein; Lan S Chen; Peng-Sheng Chen; Saqib Masroor
Journal:  Heart Rhythm       Date:  2009-01-16       Impact factor: 6.343

10.  Increased expression of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in human atria during atrial fibrillation.

Authors:  Pei De-An; Li Li; Xu Zhi-Yun; Huang Jin-Yu; Xu Zheng-Ming; Wang Min; Yao Qiang; Huang Shi-Eng
Journal:  Clin Cardiol       Date:  2010-01       Impact factor: 2.882
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.